Jakobsen AK - Search Results

1

Comments on "The evidence base of US Food and Drug Administration approvals of novel cancer therapies from 2000 to 2020".

Jakobsen AKM, Spindler KG. Jakobsen AKM, et al. Int J Cancer. 2023 Oct 1;153(7):1423-1424. doi: 10.1002/ijc.34627. Epub 2023 Jul 8. Int J Cancer. 2023. PMID: 37421183 No abstract available.

2

ctDNA-Response evaluation criteria in solid tumors - a new measure in medical oncology.

Jakobsen AKM, Spindler KG. Jakobsen AKM, et al. Eur J Cancer. 2023 Feb;180:180-183. doi: 10.1016/j.ejca.2022.11.039. Epub 2022 Dec 17. Eur J Cancer. 2023. PMID: 36610263 Free article.

3

p38γ and p38δ as biomarkers in the interplay of colon cancer and inflammatory bowel diseases.

Fajardo P, Taskova M, Martín-Serrano MA, Hansen J, Slott S, Jakobsen AK, Wibom ML, Salegi B, Muñoz A, Barbachano A, Sharma A, Gubatan JM, Habtezion A, Sanz-Ezquerro JJ, Astakhova K, Cuenda A. Fajardo P, et al. Among authors: jakobsen ak. Cancer Commun (Lond). 2022 Sep;42(9):897-901. doi: 10.1002/cac2.12331. Epub 2022 Jul 7. Cancer Commun (Lond). 2022. PMID: 35796643 Free PMC article. No abstract available.

4

Increasing rates of urinary and bloodstream infections following transrectal prostate biopsy in South Sweden.

Ljungquist O, Persmark A, Grabe M, Jakobsen AK, Gerdtsson A, Torisson G, Bjartell A, Riesbeck K. Ljungquist O, et al. Among authors: jakobsen ak. BJU Int. 2022 Oct;130(4):478-485. doi: 10.1111/bju.15713. Epub 2022 Mar 8. BJU Int. 2022. PMID: 35174613 Free PMC article.

5

TDP1 and TOP1 as targets in anticancer treatment of NSCLC: Activity and protein level in normal and tumor tissue from 150 NSCLC patients correlated to clinical data.

Jakobsen AK, Yuusufi S, Madsen LB, Meldgaard P, Knudsen BR, Stougaard M. Jakobsen AK, et al. Lung Cancer. 2022 Feb;164:23-32. doi: 10.1016/j.lungcan.2021.12.010. Epub 2021 Dec 22. Lung Cancer. 2022. PMID: 34974222 Free article.

6

A Dual-Sensor-Based Screening System for In Vitro Selection of TDP1 Inhibitors.

Jakobsen AK, Keller JG, Gonzalez M, Martin-Encinas E, Palacios F, Alonso C, Knudsen BR, Stougaard M. Jakobsen AK, et al. Sensors (Basel). 2021 Jul 15;21(14):4832. doi: 10.3390/s21144832. Sensors (Basel). 2021. PMID: 34300575 Free PMC article.

7

Topoisomerase I activity and sensitivity to camptothecin in breast cancer-derived cells: a comparative study.

Tesauro C, Simonsen AK, Andersen MB, Petersen KW, Kristoffersen EL, Algreen L, Hansen NY, Andersen AB, Jakobsen AK, Stougaard M, Gromov P, Knudsen BR, Gromova I. Tesauro C, et al. Among authors: jakobsen ak. BMC Cancer. 2019 Nov 29;19(1):1158. doi: 10.1186/s12885-019-6371-0. BMC Cancer. 2019. PMID: 31783818 Free PMC article.

8

Characterization of Camptothecin-induced Genomic Changes in the Camptothecin-resistant T-ALL-derived Cell Line CPT-K5.

Kjeldsen E, Nielsen CJF, Roy A, Tesauro C, Jakobsen AK, Stougaard M, Knudsen BR. Kjeldsen E, et al. Among authors: jakobsen ak. Cancer Genomics Proteomics. 2018 Mar-Apr;15(2):91-114. doi: 10.21873/cgp.20068. Cancer Genomics Proteomics. 2018. PMID: 29496689 Free PMC article.

9

Surgical interventions for nephrolithiasis in ankylosing spondylitis and the general population.

Jakobsen AK, Jacobsson LTH, Patschan O, Hopfgarten T, Askling J, Kristensen LE. Jakobsen AK, et al. Scand J Urol. 2015 Dec;49(6):486-491. doi: 10.3109/21681805.2015.1089523. Epub 2015 Sep 21. Scand J Urol. 2015. PMID: 26389795

10

Correlation between topoisomerase I and tyrosyl-DNA phosphodiesterase 1 activities in non-small cell lung cancer tissue.

Jakobsen AK, Lauridsen KL, Samuel EB, Proszek J, Knudsen BR, Hager H, Stougaard M. Jakobsen AK, et al. Exp Mol Pathol. 2015 Aug;99(1):56-64. doi: 10.1016/j.yexmp.2015.05.006. Epub 2015 May 16. Exp Mol Pathol. 2015. PMID: 25987486

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page